Serum levels of soluble CD163 and soluble CD14 following antibiotic therapy of patients with acute brucellosis | Zendy

Huali Sun | Zendy; Rongmeng Jiang | Zendy; Bing Han | Zendy; XiuFang Du | Zendy; Chengjie Ma | Zendy; Yanli Xu | Zendy; Zhihai Chen | Zendy; Linghang Wang | Zendy; Siyuan Yang | Zendy; Xiao Lv | Zendy; Hong Zhao | Zendy; Xingwang Li | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum levels of soluble CD163 and soluble CD14 following antibiotic therapy of patients with acute brucellosis

Author(s) -

Huali Sun,

Rongmeng Jiang,

Bing Han,

XiuFang Du,

Chengjie Ma,

Yanli Xu,

Zhihai Chen,

Linghang Wang,

Siyuan Yang,

Xiao Lv,

Hong Zhao,

Xingwang Li

Publication year - 2019

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.10602

Subject(s) - brucellosis , erythrocyte sedimentation rate , medicine , white blood cell , cd14 , antibiotics , c reactive protein , cd163 , brucella , immunology , gastroenterology , monocyte , brucella melitensis , inflammation , macrophage , immune system , biology , microbiology and biotechnology , biochemistry , in vitro

Soluble CD163 (sCD163) and soluble CD14 (sCD14) levels, monocyte/macrophage activation markers, are elevated in patient serum during Brucella infection. The aim of this study was to measure serum sCD163 and sCD14 levels during treatment for acute brucellosis to determine whether they can be used to monitor treatment efficacy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research